Tonix Pharmaceuticals (NASDAQ:TNXP) Coverage Initiated at StockNews.com
StockNews.com assumed coverage on shares of Tonix Pharmaceuticals (NASDAQ:TNXP – Free Report) in a research report sent to investors on Monday morning. The firm issued a sell rating on the stock. Separately, Alliance Global Partners raised their price target on shares of Tonix Pharmaceuticals from $6.00 to $11.00 and gave the company a buy rating […]
More Stories
Standard Lithium (CVE:SLI) Trading Up 0.8% – Here’s Why
Shares of Standard Lithium Ltd. (CVE:SLI – Get Free Report) were up 0.8% on Thursday . The company traded as...
Nitori (OTC:NCLTY) Stock Price Down 0.6% – Time to Sell?
Nitori Holdings Co., Ltd. (OTC:NCLTY – Get Free Report)’s stock price fell 0.6% on Thursday . The company traded as...
Charlotte’s Web (TSE:CWEB) Trading Up 2.8% – Time to Buy?
Charlotte’s Web Holdings, Inc. (TSE:CWEB – Get Free Report)’s share price shot up 2.8% during trading on Thursday . The...
Urban Logistics REIT (OTC:PCILF) Stock Price Down 6.8% – Should You Sell?
Urban Logistics REIT plc (OTC:PCILF – Get Free Report) shares traded down 6.8% during mid-day trading on Thursday . The...
Titan Medical (NASDAQ:TMDIF) Stock Price Up 11.7% – What’s Next?
Titan Medical Inc. (NASDAQ:TMDIF – Get Free Report)’s share price traded up 11.7% during trading on Thursday . The stock...
iShares LifePath Target Date 2050 ETF (NYSEARCA:ITDF) Trading Down 0.1% – Here’s Why
iShares LifePath Target Date 2050 ETF (NYSEARCA:ITDF – Get Free Report)’s stock price were down 0.1% on Thursday . The...